Astragalus Polysaccharide Exerts a Neuroprotective Effect in a Demyelination Model by Alleviating Oxidative Stress.
- 1School of Medicine Henan Polytechnic University Jiaozuo China.
- 2Jiaozuo Key Laboratory for Huaiyao Comprehensive Development Henan Polytechnic University Jiaozuo China.
Abstract
Multiple sclerosis (MS) is an autoimmune disease of the central nervous system characterized by progressive demyelination and neurodegenerative damage. The accumulation of reactive oxygen species (ROS) and the resulting oxidative stress are considered key contributors to myelin injury and disease progression. Astragalus polysaccharide (APS), a water-soluble polysaccharide, exhibits multiple pharmacological activities, including immunomodulatory, anti-inflammatory, antioxidant, and anti-apoptotic effects. This study aimed to investigate the therapeutic effects of APS in MS and to explore its potential mechanisms. In vivo, APS was administered intraperitoneally at 50 mg/kg/day in a cuprizone-induced demyelinating mouse model, and its effects were evaluated by immunofluorescence, immunohistochemistry, and Western blotting. In vitro, the regulatory effects of APS on oxidative stress in oligodendrocytes were assessed by immunofluorescence and Western blotting in an H2O2-induced oligodendrocyte injury model. APS significantly ameliorated myelin damage and apoptosis in vivo by inhibiting oxidative stress and attenuated oxidative stress and apoptosis in oligodendrocytes in vitro, thereby exerting neuroprotective effects. These findings indicate that APS alleviates demyelination by regulating oxidative stress, suggesting that it may represent a promising therapeutic option for the treatment of multiple sclerosis.
Related
- The role of astragalus polysaccharides in alleviating transport stress in piglets
- Astragalus Polysaccharide Hydrogel Promotes Diabetic Wound Healing by Modulating Macrophage Polarization and the Immune Microenvironment
- Concentration-Optimized Astragalus Polysaccharide-Loaded PLCL Electrospun Dressings for the Treatment of Diabetic Wounds.
- Astragalus polysaccharide exerts anti-tumor effects associated with altered TIGIT-CD155 axis expression in Lewis lung carcinoma models.
- Neuroprotective Role of PGC-1α Against Oxidative Stress and Mitochondrial Dysfunction in Chronic Pain Pathophysiology: A Review
BibTeX
@article{long2026astragalus,
title = {{Astragalus Polysaccharide Exerts a Neuroprotective Effect in a Demyelination Model by Alleviating Oxidative Stress.}},
author = {Yijiao Long and Lihui Wang and Baohua Hou},
journal = {Food science \& nutrition},
year = {2026},
month = nov,
doi = {10.1002/fsn3.72579},
url = {https://europepmc.org/article/MED/42999441},
note = {CC BY},
}
RIS
TY - JOUR
TI - Astragalus Polysaccharide Exerts a Neuroprotective Effect in a Demyelination Model by Alleviating Oxidative Stress.
AU - Yijiao Long
AU - Lihui Wang
AU - Baohua Hou
PY - 2026
DA - 2026/11/06
JO - Food science & nutrition
DO - 10.1002/fsn3.72579
UR - https://europepmc.org/article/MED/42999441
AB - Multiple sclerosis (MS) is an autoimmune disease of the central nervous system characterized by progressive demyelination and neurodegenerative damage. The accumulation of reactive oxygen species (ROS) and the resulting oxidative stress are considered key contributors to myelin injury and disease progression. Astragalus polysaccharide (APS), a water-soluble polysaccharide, exhibits multiple pharmacological activities, including immunomodulatory, anti-inflammatory, antioxidant, and anti-apoptotic effects. This study aimed to investigate the therapeutic effects of APS in MS and to explore its potential mechanisms. In vivo, APS was administered intraperitoneally at 50 mg/kg/day in a cuprizone-induced demyelinating mouse model, and its effects were evaluated by immunofluorescence, immunohistochemistry, and Western blotting. In vitro, the regulatory effects of APS on oxidative stress in oligodendrocytes were assessed by immunofluorescence and Western blotting in an H2O2-induced oligodendrocyte injury model. APS significantly ameliorated myelin damage and apoptosis in vivo by inhibiting oxidative stress and attenuated oxidative stress and apoptosis in oligodendrocytes in vitro, thereby exerting neuroprotective effects. These findings indicate that APS alleviates demyelination by regulating oxidative stress, suggesting that it may represent a promising therapeutic option for the treatment of multiple sclerosis.
SN - 2048-7177
ER -